Your browser doesn't support javascript.
loading
On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis.
Bykerk, Vivian P; Burmester, Gerd R; Combe, Bernard G; Furst, Daniel E; Huizinga, Tom W J; Ahmad, Harris A; Emery, Paul.
Afiliação
  • Bykerk VP; Department of Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, 535 East 70th St, New York, NY, 10021, USA. bykerkv@hss.edu.
  • Burmester GR; Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany.
  • Combe BG; Department of Rheumatology, Service d'Immuno-Rheumatologie, Montpellier, France.
  • Furst DE; Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Huizinga TWJ; Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands.
  • Ahmad HA; Headquarters Medical Immunology, Bristol-Myers Squibb, Princeton, NJ, USA.
  • Emery P; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
Rheumatol Int ; 38(12): 2225-2231, 2018 12.
Article em En | MEDLINE | ID: mdl-30341453

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Metotrexato / Antirreumáticos / Abatacepte / Imunossupressores Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Metotrexato / Antirreumáticos / Abatacepte / Imunossupressores Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article